Lupin launches generic fenofibrate
BALTIMORE — Lupin Pharmaceuticals has launched a generic drug for cholesterol disorders, the company said.
Lupin announced the launch of fenofibrate tablets in the 48-mg and 145-mg strengths. The drug is used to treat hypercholesterolemia or mixed dyslipidemia and severe hypertriglyceridemia.
The drug is a generic version of Abbott's Tricor, which had sales of $1.26 billion during the 12-month period ended in June, according to IMS Health.